Practical Insights for Treating Metastatic Colorectal Cancer: Bridging Research to Real-World Practice : Episode 1

Opinion

Video

September 11, 2024

Navigating Beyond FOLFOX/FOLFIRI: Key Therapies in Advanced mCRC

Author(s):

Ryan Haumschild, PharmD, MS, MBA,Marwan Fakih, MD

Medical experts review therapy options for metastatic colorectal cancer after FOLFOX/FOLFIRI, emphasizing regorafenib, FTD/TPI plus or minus bevacizumab, and fruquintinib due to the rarity of targetable biomarkers.

EP: 1.Navigating Beyond FOLFOX/FOLFIRI: Key Therapies in Advanced mCRC

EP: 2.Real-World Impact of SUNLIGHT Outcomes in mCRC

EP: 3.Fruquintinib in mCRC: Key Insights From FRESCO-2

EP: 4.Comparing mCRC Therapies: FTD/TPI Plus Bevacizumab, Fruquintinib, and Regorafenib

EP: 5.Optimizing mCRC Therapy Sequencing: Key Considerations and Future Directions

EP: 6.Guiding Patients Through Third-Line mCRC Therapy Decisions

EP: 7.Navigating Toxicity: Comparing Third-Line mCRC Therapies

EP: 8.Evaluating Quality of Life and Adherence With mCRC Treatment Options

EP: 9.Integrating Support Services and Caregiver Roles in mCRC Care

EP: 10.mCRC Treatment Access: IRA Cost Cap Impact and Final Insights

Provide a brief overview of our therapy options in metastatic colorectal cancer that has progressed after FOLFOX/FOLFIRI.

Discuss the importance of biomarker screening.
A majority of patients will not have targetable biomarkers, so provide emphasis on the 3 therapies: regorafenib, FTD/TPI plus or minus bevacizumab, and fruquintinib.

Related Videos

1 KOL is featured in this series.

1 KOL is featured in this series.

Justin Oldham, MD, MS, an expert on IPF

Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.

Dr Bonnie Qin

Screenshot of an interview with Ruben Mesa, MD

Justin Oldham, MD, MS, an expert on IPF

Ruben Mesa, MD

Amit Garg, MD, Northwell Health

4 KOLs are featured in this series

Related Content

Palliative care | Image Credit: Chinnapong - stock.adobe.com

November 22nd 2024

Early Palliative Care Linked to Better End-of-Life Outcomes in Ovarian Cancer

Brooke McCormick

Initiating palliative care more than 3 months before death improves end-of-life outcomes for patients with ovarian cancer, highlighting the need for earlier interventions.

Managed Care Cast

October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi

Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.

BMI - Olivier Le Moal

November 21st 2024

Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link

Kimberly Rath, PharmD

A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.

July 18th 2024

Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.

Closeup of hand with cardiogram on red heart | Image Credit: Syda Productions - stock.adobe.com

November 21st 2024

Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk

Brooke McCormick

Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.

WINSTON KIRTON, JD | Image credit: Courtesy of Winston Kirton

November 20th 2024

As Myeloma Trials Tackle Frontline Treatment, Where Are the Black Patients?

Ryan Flinn Mary Caffrey

Related Content

Palliative care | Image Credit: Chinnapong - stock.adobe.com

November 22nd 2024

Early Palliative Care Linked to Better End-of-Life Outcomes in Ovarian Cancer

Brooke McCormick

Initiating palliative care more than 3 months before death improves end-of-life outcomes for patients with ovarian cancer, highlighting the need for earlier interventions.

Managed Care Cast

October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi

Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.

BMI - Olivier Le Moal

November 21st 2024

Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link

Kimberly Rath, PharmD

A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.

July 18th 2024

Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.

Closeup of hand with cardiogram on red heart | Image Credit: Syda Productions - stock.adobe.com

November 21st 2024

Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk

Brooke McCormick

Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.

WINSTON KIRTON, JD | Image credit: Courtesy of Winston Kirton

November 20th 2024

As Myeloma Trials Tackle Frontline Treatment, Where Are the Black Patients?

Ryan Flinn Mary Caffrey

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions